跳至主要内容
临床试验/NCT00249886
NCT00249886撤回3 期

Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents

Sunnybrook Health Sciences Centre2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2002年9月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
撤回
入组人数
60
试验地点
2
主要终点
Relapse - subject meets criteria for an episode of major depression for 2 weeks or more.

研究概览

简要总结

The purpose of the study is to evaluate whether it is advantageous for adolescents who have recovered from depression after a 6 to 12 week course of antidepressant treatment to stay on the treatment a further 6 months or is it just as helpful to stop the medication after recovery.

The hypothesis is that adolescents with major depression who recover from the 6 to 12 week trial of citalopram will be less likely to have a recurrence of depression over a 6 month period if continued on the citalopram as compared to those who discontinue the medication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
13 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of major Depression.
  • A score of > 16 on the 17 item Hamilton Depression Scale or a score of > 12 on the 17 items plus a score of >7 on the atypical items.
  • Males and females.
  • Outpatient at initiation of double blind treatment phase.
  • Ability to give informed consent.

排除标准

  • Past or current hypomanic or manic episode.
  • Currently meets criteria for a Conduct Disorder.
  • Current psychotic symptoms.
  • Substance dependence in the last 3 months.
  • Significant medical condition that would contraindicate the use of an antidepressant.
  • Pregnancy
  • Past treatment with Citalopram for major depression

结局指标

主要结局

Relapse - subject meets criteria for an episode of major depression for 2 weeks or more.

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验